Black Diamond Therapeutics BDTX
NASDAQ BDTX
$2.08 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Black Diamond Therapeutics (BDTX) Price to Sales (2025)

Updated

Black Diamond Therapeutics' (BDTX) Price to Sales was 1.98 for Q4 2025, down 35.7% from the prior quarter.

Analysis

Black Diamond Therapeutics (BDTX) Price to Sales (2025) Analysis & Trends

Dating back to Q1 2025, Black Diamond Therapeutics' Price to Sales record includes 4 quarters.

  • Five-year quarterly Price to Sales spans a low of 1.25 in Q1 2025 and a high of 3.08 in Q3 2025.
  • Per Business Quant data, the three quarters before Q4 2025 came in at 3.08 (Q3 2025), 2.02 (Q2 2025) and 1.25 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Black Diamond Therapeutics 119.32 Mn -373.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.98
Sep 30, 2025 3.08
Jun 30, 2025 2.02
Mar 31, 2025 1.25
API Access

Black Diamond Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=BDTX&period=max&api_key=YOUR_API_KEY